Knowell Pharma Solutions Llp Profile
Key Indicators
- Obligation of Contribution ₹ 0.10 M
- Company Age 14 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 11.52 Cr
- Revenue Growth 24.25%
- Profit Growth 108.09%
- Ebitda 3654.82%
- Total Assets 4.24%
About Knowell Pharma Solutions Llp
Knowell Pharma Solutions Llp (KPSL) is 14 Year, 9 Months old Limited Liability Partnership 06 May 2010. Its registered office is in Delhi, Delhi.
The LLP status is Active, and it has filed its Accounts and Solvency Statement up to 31 Mar 2023 (FY 2022-2023). It's Total Obligation of Contribution is Rs 0.10 M as per MCA.
Company Details
- Location Delhi, Delhi
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN/FCRN
AAA-1298
- Incorporation Date
06 May 2010
- Date of Accounts and Solvency Statement
31 Mar 2023
- ROC Code
Roc-Delhi
- Company Classification
Limited Liability Partnership
Industry
Who are the key members and board of directors at Knowell Pharma Solutions Llp?
Designated Partners (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Anand  | Designated Partner | 10-Jan-2019 | Current |
| Varun Anand | Designated Partner | 06-May-2010 | Current |
| Karan Anand | Designated Partner | 10-Jan-2019 | Current |
| Kanika Anand | Designated Partner | 06-May-2010 | Current |
Financial Performance of Knowell Pharma Solutions Llp.
Knowell Pharma Solutions Llp, for the financial year ended 2021, experienced significant growth in revenue, with a 24.25% increase. The company also saw a substantial improvement in profitability, with a 108.09% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Knowell Pharma Solutions Llp?
Unlock access to Knowell Pharma Solutions Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Kaj Biofarma LlpKaran Anand is a mutual person
Charges (Loans)
₹115.19 M
₹0
Charges Breakdown by Lending Institutions
- Housing Development Finance Corporation Limited : 6.32 Cr
- The Hongkong And Shanghai Banking Corporation Limited : 4.00 Cr
- Hdfc Bank Limited : 1.20 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Dec 2022 | Hdfc Bank Limited | ₹1.20 Cr | Open |
| 28 Sep 2022 | The Hongkong And Shanghai Banking Corporation Limited | ₹4.00 Cr | Open |
| 30 Jul 2022 | Housing Development Finance Corporation Limited | ₹3.52 Cr | Open |
| 30 Jul 2022 | Housing Development Finance Corporation Limited | ₹2.80 Cr | Open |
How Many Employees Work at Knowell Pharma Solutions Llp?
Unlock and access historical data on people associated with Knowell Pharma Solutions Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Knowell Pharma Solutions Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Knowell Pharma Solutions Llp's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.